2012 IW 1000 Company Profile

Novartis AG
Pharmaceuticals
Switzerland
2012 IW 1000 Rank:
Current Rank : 61
Prior Rank : 71
Executive 1 : Mr. Joseph Jimenez, Chief Executive Officer
Executive 2 : Dr. Juergen Brokatzky-Geiger, Ph.D., Head
61 of 1000
Earnings Per Share Growth (%)(11.27%)
Cost of Goods Sold (US$ Millions)$18,983
Current Liabilities (US$ Millions)$23,148
Total Assets (US$ Millions)$24,084
Long Term Debt13855
Return on Equity14.63
Market Capitalization (US$ Millions)$137,590
Price to Earnings Ratio16.85
Revenue (US$ Millions)$60,729
Total Company Assets$117,496
Revenue Growth (%)15.03%
Net Income (US$ Millions)$9,245
Earnings Per Share (US$)$3.78
Total Equity (US$ Millions)$65,844
Profit Margin (%)15.22%
Debt To Equity Ratio (%)0.21%
Inventory Turnover5930

Subscribe to IW Newsletters

IW Marketplace - Buy a Link Now